PUCCI, FRANCESCA
 Distribuzione geografica
Continente #
AS - Asia 125
NA - Nord America 81
EU - Europa 66
SA - Sud America 32
AF - Africa 2
Totale 306
Nazione #
US - Stati Uniti d'America 76
SG - Singapore 67
BR - Brasile 29
IT - Italia 24
CN - Cina 18
HK - Hong Kong 16
VN - Vietnam 14
GB - Regno Unito 9
NL - Olanda 7
DE - Germania 4
AT - Austria 3
FR - Francia 3
MX - Messico 3
SE - Svezia 3
BD - Bangladesh 2
CA - Canada 2
CH - Svizzera 2
FI - Finlandia 2
ID - Indonesia 2
PL - Polonia 2
RU - Federazione Russa 2
UA - Ucraina 2
ZA - Sudafrica 2
BY - Bielorussia 1
CL - Cile 1
EC - Ecuador 1
ES - Italia 1
IE - Irlanda 1
IQ - Iraq 1
JO - Giordania 1
JP - Giappone 1
KR - Corea 1
PK - Pakistan 1
PY - Paraguay 1
UZ - Uzbekistan 1
Totale 306
Città #
Singapore 38
Ashburn 19
Hong Kong 16
Santa Clara 13
Beijing 10
Arnhem 6
Ho Chi Minh City 5
Hanoi 4
London 4
Bologna 3
Chicago 3
Elk Grove Village 3
Salt Lake City 3
Stockholm 3
Brasília 2
Houston 2
Los Angeles 2
Mexico City 2
Milwaukee 2
Naples 2
Pregassona 2
Sterling 2
Amman 1
Ann Arbor 1
Apucarana 1
Asunción 1
Barcarena 1
Betim 1
Bom Jesus da Lapa 1
Boston 1
Brooklyn 1
Buffalo 1
Cachoeiras de Macacu 1
Campinas 1
Cape Town 1
Cotia 1
Denver 1
Diadema 1
Dublin 1
Edmonton 1
Erbil 1
Espírito Santo 1
Fairfield 1
Feira de Santana 1
Formiga 1
Frankfurt am Main 1
Guangzhou 1
Guarujá 1
Guayaquil 1
Ha Long 1
Hefei 1
Helsinki 1
Hải Dương 1
Iztapalapa 1
Jakarta 1
Johannesburg 1
Kita 1
Lappeenranta 1
Limeira 1
Manaus 1
Manchester 1
Maricá 1
Minsk 1
Montreal 1
Moscow 1
Multan 1
Munich 1
New York 1
Norwalk 1
Nuremberg 1
Orem 1
Parnaíba 1
Petrolina 1
Portsmouth 1
Poá 1
Princeton 1
Puerto Natales 1
Quatá 1
Raleigh 1
Rome 1
Rondonópolis 1
Santa Rosa 1
Sukabumi 1
São Lourenço 1
Tampa 1
Tashkent 1
Teresina 1
Thành Phố Bà Rịa 1
Tietê 1
Torres 1
Valparaíso de Goiás 1
Vienna 1
Warsaw 1
Wilmington 1
Totale 218
Nome #
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas 89
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial 82
SOCIAL HUB. Inclusione come motore di rigenerazione urbana nell’area dell’ex Foro Boario a Ferrara 75
Decoupling pulse tube vibrations from a dry dilution refrigerator at milli-Kelvin temperatures 32
NUCLEUS: cryogenic calorimeters to detect coherent nuclear scattering of reactor antineutrino 23
Sub-keV Electron Recoil Calibration for Macroscopic Cryogenic Calorimeters Using a Novel X-ray Fluorescence Source 15
Totale 316
Categoria #
all - tutte 1.661
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.661


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 3 0 0 0
2021/20226 0 0 0 2 0 1 0 0 1 0 0 2
2022/20234 1 0 1 0 1 0 0 1 0 0 0 0
2023/20247 0 0 0 0 0 0 0 0 0 0 0 7
2024/202597 2 2 6 4 13 13 2 0 12 26 12 5
2025/2026199 28 13 25 50 78 5 0 0 0 0 0 0
Totale 316